End of life care Flashcards

1
Q

Basic principles of prescribing opioid analgesia in Palliative Care: How should PRN and potency be adjusted?

A
  • PRN Morphone should be one-sixth of total 24hr dose

* Potency (PO:SC = 2:1)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Analgesia in Palliative Care: 65yrs, Carcinoma of breast
• Takes: morphine modified release 30mg BD
• Admitted to hospital with urine infection

Please prescribe her analgesia

A

Regular opioid:
• Dose: 30mg modified release
• Frequency: 12-hourly (BD)

PRN opioid:
• PO: morphine immediate
release 10mg four-hourly
• SC: morphien injection 5mg fourhourly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Analgesia in Palliative Care: Patient with gastric cancer taking Oxycodone modified release 100mg BD, Admitted with vomiting

What should she be prescribed regular & PRN?

A

Regular opioid:
• Dose: oxycodone 100mg
CSCI/24hrs#
• Frequency: over 24hrs

PRN opioid:
• PO: ?
• SC: oxycodone injection 15mg-20mg four hourly PRN

#Note frequency of dose important ie
csci is over 24hrs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Analgesia in Palliative Care: Patient with Fentanyl
transdermal patch 25micrograms/hour

What would you want to know?
How do you work out a PRN dose?

A
• Check renal function
• Consult patient and BNF
• Fent 25mcg/hr = ~90 oral
morphine in 24hrs
• PO morphine PRN dose ~15mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Controlled Drug prescriptions must include which elements?

A
DRUG
• Name
• Formulation: liquid, tablet, capsule, patch etc
• Dose: in words and figures
• Frequency
• Strength: eg 10mg in 5mL, 10mg tablets
• Total quantity (words & figures)

YOU: Prescriber signature, date, address [professional]

PATIENT: name & address, date of birth, hospital/NHS number

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Analgesia in Palliative Care: Syringe drivers - what is an appropriate starting dose?

A
  • Morphine 10mg/24hrs
  • Oxycodone 5mg/24hrs
  • Alfentanil 500micrograms/24hrs

In renal failure: use fentanyl or alfentanil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Complete a MCCoD:
• 64 years, admitted to hospital with chest infection.
• Underlying diagnosis of squamous cell lung cancer, bone metastases.
• Deteriorated despite IV antibiotic. Commenced on
PCPDP.
• PMHx: eczema, hypertension

A
I(a) Lower respiratory tract infection
(b) Metastatic squamous cell
carcinoma of the lung.
(c) -
II -
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Complete a MCCoD:
• 54yrs
• Cardiac failure, EF 25%
• PMHx: multiple MIs, angioplasty + stent; Has CRT-P, Diabetes.
• Admitted with pulmonary oedema, deteriorated despite treatment and died suddenly.

A

I(a) Cardiac failure
(b) Ischaemic Heart Disease
(c)
II Diabetes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Complete a MCCoD:
• 73yrs male
• Admitted with dyspnoea. Found to have pulmonary embolism,
• Deterioration, hospice admission or end of life care 29th July 2018
• Mesothelioma diagnosed 2017
• VATS surgery 2018 (Jan)

A

You must refer this death to Coroner as mesothelioma

industrial disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Delirium in palliative care: What is delirium?

A
  • Acute confusional state
  • Change in alertness, altered consciousness, impaired cognition
  • Fluctuant /Reversible course
  • Change from normal baseline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What factors can precipitate delirium?

A
D: Drugs, Dehydration
E: Electrolyte /Endocrine Imbalance
L: Level of pain
I: Infection /Inflammation
R: Respiratory Failure
I: Impaction
U: Urinary retention
M: Metabolic disorder ( Liver/Renal failure, Hypoglycemia)
  • Change of environment
  • Sensory deficit
  • Falls
  • Immobility
  • Sleep Deprivation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Symptoms of Delirium

A

• Cognition : concentration, disorientation, fluctuating
consciousness

• Perception : hallucinations

• Impaired Physical function : mobility, appetite, agitation,
restlessness, sleep disturbance

• Social behaviour : combative, lack of cooperation with
reasonable requests, withdrawal

• Attention : difficulty maintaining attention span

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

4 features of hyperactive delirium

A
  • Aggressive, restless, agitated
  • Increased state of arousal
  • Hallucinations, delusions
  • Sleep disturbed, , hyper vigilant
  • Uncooperative, combative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

4 features of hypoactive delirium

A
  • Withdrawn, quiet, sleepy
  • Less active / inert
  • Poor concentration
  • Reduced mobility /movement
  • Mimics depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does the onset differ between delirium, depression and dementia?

A

Delirium: hours to days

Depression: gradual weeks o months

Dementia: gradual months to years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How does the course differ between delirium, depression and dementia?

A

Delirium: fluctuant, reversible with treatment

Depression: recent changes in mood persistent, worse in morning

Dementia: show chronic progression, irreversible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

How does sleep differ between delirium, depression and dementia?

A

Delirium: disturbed sleep with no set pattern, some day night reversal

Depression: early morning awakening, hypersomnia, disturbed

Dementia: disturbed +/- individual pattern occurring most nights, nocturnal wandering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

How does mood differ between delirium, depression and dementia?

A

Delirium: fluctuant emotions, labile, may have outburst of anger, fearfulness or crying

Depression: withdrawn, persistently low, worthlessness, anhedonia, hopelessness, suicidal

Dementia: depressed, apathy more common

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How does perception and cognition differ between delirium, depression and dementia?

A

Delirium: Fluctuation in alertness, cognition, Perception,
hallucinations, illusions

Depression: Low self esteem & guilt, Suicidal / self harm
Agitated depression OR withdrawn, reduced motivation/interest

Dementia: Delusions +/-
Hallucinations – LBD
Wandering /agitated or withdrawn, co-existent
depression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

How do you assess a patient for delirium?

A

Altered arousal: observe for sleepiness or hyper-alertness, wake them up and talk to them - are they able to follow conversation?

Disordered thinking: “what’s going on today? Anything strange or different?”

Change in baseline: acute onset, fluctuant course, not my mom/dad

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Formal tools for assessing delirium

A

DSM-5 Criteria
CAM - confusion assessment method
4AT
AMTS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Describe the confusion assessment method (CAM) tool

A
  1. acute onset and fluctuant course
  2. inattention
  3. disordered thinking
  4. altered consciousness

Must have presence of 1,2 AND
Either 3 OR 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

DSM-5 Diagnostic Criteria for Delirium

A

A. Disturbance in attention and awareness
B. Develops over a short period of time, Fluctuates in severity
during the course of a day
C. Additional disturbance in cognition not accounted for by
another neurocognitive disorder;
D. Disturbances A and C must not be occurring secondary to
coma;
E. Caused by a somatic factor, medication intoxication or
withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Non Pharmacological Management of delirium

A
  • Calm, constant environment
  • Correct sensory deficit
  • Familiar objects & people
  • Simple communication/reassure in lucid intervals
  • Avoid moving patient between rooms
  • Fewer interruptions
  • Avoid catheterisation, restraints
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Which reversible causes of deliruim should be treated in palliative patients?

A

Treat potentially reversible causes EVEN in
palliative patients
- Infections: UTI, pneumonia, sepsis
- metabolic: Ca, Na, HF, RF, hypoglycaemia
- dehydration and nutritional deficiencies
- psychological distress, pain
- constipation, urinary retention

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Pharmacological Management of delirium: what works?

A
Haloperidol
• Oral & s/c syringe driver
• 500 micrograms stat, PRN
• Dose range 0.5 mg - 3 mg
• Lower doses in elderly
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Pharmacological Management of delirium: What cautions must be think about when prescribing haloperidol?

A
  • Parkinson’s Disease, Levy Body Dementia

* Prolonged QT interval, torsade de pointes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Pharmacological Management of delirium: what should be avoided?

A

• Benzodiazepines WORSEN delirium
• No adequately controlled trials to support the use of
Benzodiazepines in Delirium
• Lorazepam associated with increased side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Strategies to prevent delirium

A
  • Orientate
  • Hydration / nutrition
  • Reassure – use lucid intervals
  • Correct sensory deficit
  • Encourage visits from family
  • Familiarize with surroundings
  • Encourage mobility
  • Establish sleeping pattern
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

List 3 benefits of early palliation

A
Better QOL
Less depression
Less aggressive
EOLC
Low symptom burden
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Causes of sudden onset breathlessness

A

asthma
pulmonary oedema
pneumonia
pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Causes of breathlessness arising over several days

A

exacerbation of COPD
pneumonia
bronchial obstruction by tumour
SVC obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Causes of breathlessness with gradual onset

A
congestive cardiac failure
anaemia
pleural effusion 
primary/secondary lung carcinoma 
ascites
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Dyspnea in patient with underlying malignancy: how can we determine the cause

A

malignancy related: directly or indirectly

unrelated: pre-existing pulmonary or cardiovascular disease

treatment related: directly or indirectly

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

How can malignancy cause dyspnea?

A

Directly:

  • pulmonary: lung primary or metastases, lymphangitis spread, lobar collapse, haemorrhage
  • cardiac: pericardial effusion
  • other: SVC obstruction, dyspnea of malignancy

Indirectly:

  • PE from hypercoagulability
  • pneumonia from immunosuppression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

How can treatment for malignancy cause dyspnea?

A

Radiation: pneumonitis, pulmonary fibrosis, pericarditis

Chemotherapy: lung toxicity (bleomycin, methotrexate etc), cardiac toxicity (anthracyclines, paclitaxel, Herceptin)

Indirectly: pancytopenia resulting in respiratory infection or severe anaemia, higher risk of CAD with chest wall radiation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Treatment of dyspnoea in palliative patients

A

Treat potentially reversible causes of Dyspnoea
EVEN in palliative patients

Examples:
Large airway: strent

Small airway: bronchodilators

Decreased gas exchange: ?PE -> LMWH

RT pneumonitis: dexamethasone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Palliation of Breathlessness

Non pharmacological

A
  • Positioning
  • Room temperature, air circulation
  • Behavioral techniques, relaxation, distraction
  • Energy conservation / Pacing
  • Controlled breathing
  • Loose clothing
  • Mouth care
  • Walking Aids
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Palliation of Breathlessness

pharmacological management

A
  • Bronchodilators
  • Nebulised saline
  • Carbocistiene
  • Dexamethasone

Benzodiazepine if anxiety unmanageable or EOL (less evidence for this)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Palliation of Breathlessness: What is the role of oxygen?

A

Oxygen no better than air in palliation
A fan may be equally effective
Only for hypoxic patients
Formal assessment for O2 use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Define Cachexia

A

Multifactorial syndrome associated with protein and muscle loss, as well as systemic inflammation. Traditionally described as involuntary loss of more than 10% of premorbid body weight, Accompanying anorexia. Increases with disease progression.

Can be caused by Cancer, AIDS, heart failure, COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Factors exacerbating anorexia in cancer patients

A
  • dry mouth from mouth breathing and oxygen therapy
  • drugs: opioids, iron, NSAID
  • disease processes - mouth ulcers, candida, mucositis
  • treatment related: post-chemo or radiation
  • anxiety, depression, pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Effects of anorexia/cachexia in cancer patients

A
  • Impaired immune response
  • Impaired wound healing
  • Weakened skeletal muscles
  • Weakened respiratory function and mobility
  • Poor cardiac contractility
  • Reduced quality of life
  • Poorer prognosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Management of anorexia in cancer patients

A
•Address factors reducing intake
•Little & often
•High protein / energy meals
•“What you fancy”
•Food fortification and supplements
•Food & fluids separately
•Appetite stimulants: Alcohol, Antidepressants, Dexamethasone (glucocorticoid) 2mg mane with
PPI, (Megestrol acetate)

Down-regulation of the inflammatory response: •NSAIDs
•Inhibition of IL-6, TNF-a
•Managing insulin resistance?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Causes of nausea and vomiting in palliative cancer care

A
  • Gastric stasis, outflow obstruction, squashed stomach
  • Bowel obstruction
  • Pharyngeal candida
  • Radiotherapy & chemotherapy
  • Brain tumour or metastases
  • Metabolic - hypercalcaemia, uraemia, tumour toxins
  • Drugs (opioids, NSAIDs, iron)
  • Pain, cough
  • Anxiety/fear of treatment
46
Q

Non pharmacological management of nausea and vomiting in palliative cancer care

A
  • Control malodour (tumour, colostomy, ulcer)
  • Avoid strong food smells
  • Someone else cooks
  • Calm, unhurried meals
  • Small portions
  • Acupressure bands
47
Q

Which drugs stimulate N/V via gastric irritation?

A

Antibacterials, Corticosteroids, Iron, NSAIDs

48
Q

Which drugs stimulate N/V via gastric stasis?

A
  • Antimuscarinics (e.g. Tricyclic antidepressants)

* Opioids

49
Q

Which drugs stimulate N/V via central stimulation?

A
  • Opioids
  • Antibacterials
  • Cytotoxics
50
Q

Which drugs stimulate N/V via 5HT3 receptor stimulation?

A
  • Antibacterials
  • Cytotoxics
  • SSRIs
51
Q

Causes of N/V via central stimulation (dopamine, serotonin, NK1)

A

uraemia
hypercalcaemia
morphone

52
Q

Causes of N/V via GI tract (serotonin, dopamine, stretch receptors)

A

abdominal radiotherapy
chemotherapy
distension

53
Q

Causes of N/V via 8th nerve nucleus (AChM, H2)

A

motion sickness

vertigo

54
Q

Causes of N/V via cerebral cortex (GABA, serotonin, D2)

A

fear, anxiety, anticipatory nausea

55
Q

Which anti-emetics work as D2 antagonist?

A

metoclopramide, domperidone, haloperidol, olanzapine, levomepromazine

56
Q

Which anti-emetics work as H2 antagonist?

A

Cyclizine

Levomepromazine

57
Q

Which anti-emetics work as muscarinic antagonists?

A

Cyclizine
Olanzapine
Levomepromazine

58
Q

Which anti-emetics work as 5HT antagonists?

A

5HT2:
Olanzapine
Levomepromazine

5HT3:
Ondansetron

59
Q

Which anti-emetic works as NK1 antagonists?

A

Aprepitant

60
Q

How does metoclopramide act as a pro kinetic?

A

D2 antagonist (Upper GIT, CTZ)

5HT4 agonist (Upper GIT)

Triggers cholingeric system in GIT wall

Crosses BBB

61
Q

Indications for metoclopramide as pro kinetic

A

Gastric stasis/upper GI dysmotility
Early in bowel obstruction
Delayed N&V due to chemotherapy

62
Q

Side effects and cautions of metoclopramide as pro kinetic

A
Diarrhoea
Extrapyramidal reactions (avoid in Parkinsons disease)
63
Q

Indications for domperidone as pro kinetic

A

Gastric stasis/upper GI dysmotility

64
Q

Key difference between pro kinetics metoclopramide and domperidone

A

metoclopramide crosses the BBB whereas domperidone does not

65
Q

Action of Cyclizine

A
  • AchM (antimuscarinic antihistamine)
  • directly on vomiting centre
  • Decreases activity in vestibular system
66
Q

Indications for Cyclizine

A
  • Raised ICP

* Motion induced nausea and vomiting

67
Q

Cyclizine: Side effects/cautions

A
  • Mutual antagonistic effect with Metoclopramide

* Severe cardiac failure (tachycardia)

68
Q

Action of Haloperidol as anti-emetic

A
  • Potent D₂ antagonist
  • Acts directly on CTZ
  • May have some gastric prokinetic effect
69
Q

Indications for Haloperidol as anti-emetic

A
  • Metabolic causes (e.g. renal failure, hypercalcaemia)
  • Morphine induced sickness
  • May help obstructive vomiting in small doses
70
Q

Side-effects and cautions for Haloperidol as anti-emetic

A
  • Some sedation

* Avoid if possible in Parkinsons disease

71
Q

Action of Olanzapine as anti-emetic

A
  • Antagonist at
  • Multiple D receptors
  • Muscarinic receptors
  • Multiple 5HT receptors
  • H₁ receptors
72
Q

Indications for Olanzapine as anti-emetic

A

Chemotherapy induced nausea and vomiting resistant to other drugs

73
Q

Cautions and side effects of Olanzapine as anti-emetic

A

Can cause:
•Drowsiness
•Orthostatic hypotension

74
Q

Action of levomepromazine as anti-emetic

A

Antagonises D₂, 5HT₂ₐ, muscarinic receptors

75
Q

Indications for levomepromazine as anti-emetic

A
  • Broad spectrum – helps with many causes of vomiting
  • Anxiolytic
  • (Used in larger doses for agitation at the end of life)
76
Q

Cautions and side effects of levomepromazine as anti-emetic

A

Drowsiness at doses >25mg/24hrs – therefore not used first line

77
Q

Action of ondansetron as anti-emetic

A
  • 5HT₃ antagonists

* Block effect on vagal nerve

78
Q

Indications for ondansetron as anti-emetic

A
  • Developed to control sickness associated with highly emetogenic chemotherapy
  • Any situation where 5HT₃ is released in excess:
  • Radiation induced damage to GI mucosa
  • Intestinal distension
  • Severe renal impairment with platelet release of 5HT
79
Q

Side effects of ondansetron as anti-emetic

A
  • Headache

* Constipation

80
Q

Action of Aprepitant as anti-emetic

A
  • Potent NK₁ inhibitors

* Act at CTZ

81
Q

Indications for Aprepitant as anti-emetic

A
  • Delayed phase of chemotherapy induced emesis

* Combination therapy with Dexamethasone and 5HT₃ inhibitor

82
Q

Side effects/cautions for Aprepitant as anti-emetic

A

Lassitude, constipation, decreased appetite, dyspepsia, headache, hiccups

83
Q

Actions and indications of dexamethasone as anti-emetic

A
  • Direct action on vomiting centre,
  • Direct anti-inflammatory effect on damaged tissue
  • Reduces expression of serotonin receptors
  • Reduces swelling around solid tumour mass
  • Short term relief of ICP due to brain metastases (use up to 2 weeks)
84
Q

Side effects/cautions for dexamethasone as anti-emetic

A
  • Arousal/disturbed sleep
  • Psychosis
  • Hyperglycaemia
  • Myopathy
  • Increased susceptibility to infection
85
Q

Actions and indications of lorazepam as anti-emetic

A

Action: GABAmimetic (cerebral cortex)

Indications:
•Chemo related and post op nausea and vomiting
•? Anxiolytic for anticipatory nausea

86
Q

Side effects/cautions for lorazepam as anti-emetic

A
  • Drowsiness
  • Can cause respiratory depression
  • Paradoxical agitation (<10%, risk in psychiatric comorbidity)
87
Q

Choice of antiemetic

Raised intracranial pressure or vestibular irritation

A

Start with centrally acting drug, e.g. Cyclizine

88
Q

Choice of antiemetic

Chemical cause of vomiting (CTZ), such as Morphine, hypercalcaemia, renal failure

A

Start with drug acting principally at CTZ, e.g. Haloperidol

89
Q

Choice of antiemetic

Gastritis, gastric stasis, functional bowel obstruction

A

Start with a prokinetic, e.g. Metoclopramide

90
Q

Management of constipation

A
  • Ask about bowel function frequently
  • Increase fluid intake
  • Increase fruit/fibre in diet
  • Encourage mobility
  • Assist to toilet/raised toilet seat
  • Provide privacy
91
Q

How do direct stimulant laxatives work?

A

Direct stimulants
•Act by direct contact with submucosal and myenteric plexus, stimulating peristalsis
•Increase water secretion into bowel lumen
•Softer, larger stool stimulates bowel

92
Q

How do softener laxatives work?

A
  • Act as detergent, allowing water to penetrate stool

* Softer, larger stool stimulates bowel

93
Q

How do osmotic laxatives work?

A
  • Retain water in bowel lumen

* Softer, larger stool stimulates bowel

94
Q

List 3 oral laxatives and how they work

A

Softener:
•Docusate tablet or liquid (100-200mg BD)

Osmotic:
•Macrogol (Movicol or Laxido, in 100ml water)

Direct stimulant:
•Senna tablet or liquid, 7.5-15mg nocte

Combination:
•Sodium picosulphate tablet or liquid 5-15mg nocte

Reversal of opioid induced constipation:
•Methylnaltrexone SC (stop other laxatives)
•Naloxegol PO (evidence lacking in palliative patients)

95
Q

List 3 rectal laxatives and how they work

A

Suppositories
•Glycerine (stool softening)
•Bisacodyl (rectal stimulant)

Enemas
•Phosphate (osmotic)
•Sodium citrate Microlax (osmotic)
•Arachis oil (softening, avoid in peanut allergy)

96
Q

“Spinal regime” for laxatives in palliative care

Lack of peristalsis due to malignant spinal cord compression or neurological disease

A

•Alternate nights: Senna 1-2 tablets PO

Following mornings
•Glycerine suppository
•Bisacodyl suppository
•Microlax enema

97
Q

Bowel obstruction in palliative care: what is Medical management?

A

Likely to represent peristaltic failure, Try to get the bowel going…
•Metoclopramide via CSCI, 30-100mg/24hrs
•Stool softening laxative (stop stimulants)
•Consider Dexamethasone 6mg SC OD for 5-7 days with Ranitidine 300mg/24hrs CSCI

May resolve partial proximal obstruction
May precipitate colic or vomiting in complete obstruction

98
Q

Bowel obstruction in palliative care: what is Medical management of colic?

A

May represent mechanical obstruction
Stop prokinetics and stimulant laxatives
Use CSCI:
•Opioid for pain
•Cyclizine and/or Haloperidol for nausea/vomiting
•Hyoscine butylbromide for colic 30-120mg/24hrs
•Consider nasogastric tube (only for large volume frequent vomits)

99
Q

Pain management in palliative care: 46yrs female with Carcinoma of lung and Widespread cutaneous metastases. Pain in skin metastases; dull ache; constant

  • What is pain?
  • What type of pain do you think this person is describing?
  • What else would you want to ask?
  • What analgesics would you use?
A
  • Nociceptive pain
  • Recognise
  • Assess: Pain history: [type], severity

•Treat
Non-opioids: paracetamol, ibuprofen
Opioids: morphine

100
Q

Pain management in palliative care: 70yrs male with lung cancer with right axillary mass, Shooting pain with pins and needles down right arm.

What type of pain do you think this person is describing?
What else would you want to ask?
What analgesics (groups) might you use?
A

Neuropathic pain

  • Recognise
  • Assess: Pain history: [type], severity
  • Treat: Neuropathic analgesics
101
Q

Total pain: management

A

pharmacological
•As nociceptive/neuropathic pain
•But caution: potential to escalate drugs with no benefit (be prepared to reduce)

Non-pharmacological
•TENS, acupuncture
•Physio
•Counselling
•Address social issues
•Manage anxiety/depression
•Distraction
102
Q

Pain management in palliative care: What practical things do you need to consider when choosing a painkiller?

A
  • Costs
  • Mode (ease) of delivery & dosing – PO, SC, TD, CSCI
  • Toxicities (more later in renal disease)
  • Regular, route, re-assess (titrate)
  • Potencies PO:SC (IM)
  • 2:1 for morphine, oxycodone
103
Q

Pain management in palliative care: Starting dose for syringe driver opioids

A
  • morphine 10mg/24hrs
  • Oxycodone 5mg/24hrs
  • Alfentanil 500micrograms/24hrs
104
Q

Pain management in palliative care: Starting dose for syringe driver non-opioids

A
  • ketorolac 30-90mg/24hrs

- ketamine 100-500mg/24hrs

105
Q

Pain management in palliative care: special considerations for opioid prescribing

A
  • Driving
  • Tolerance, Dependence, Addiction?
  • Travel abroad
  • Patient Information Leaflets
  • What questions/concerns do you think a patient may have when starting opioids for the first time?
106
Q

Pain management in palliative care: Management of Total pain at end of life “pain crisis”

A

Requires rapid, multi-modal treatment escalation

Environment, family/friends

Analgesia:
•Opioid – one hourly & CSCI
•Ketamine CSCI

Sedative anxiolytics
•Midazolam PRN & CSCI
•Levomepromazine

107
Q

Pain management in palliative care: List 4 drugs that could be used for muscle spasm and spasticity

A

baclofen, clonidine, clonazepam, tizanidine, gabapentin, ?Sativex

108
Q

painful syndromes in end-stage renal disease?

What might you ned to consider about pharmacokinetics/dynamics?

A
  • Renal osteodystrophy
  • Muscle spasms, cramp, restless legs
  • Diabetic problems – neuropathy
  • Ischaemic pain (IHD, PVD), calciphylaxis
  • Medications affecting renal perfusion: NSAIDS
  • In dialysis: some medications removed (fentanyl is not) - paracetamol, tramadol, morphine, gabapentin
109
Q

Analgesia in end-stage renal disease: What might you need to consider about pharmacokinetics/dynamics?

A
  • Medications affecting renal perfusion: NSAIDS
  • In dialysis: some medications removed (fentanyl is not) - paracetamol, tramadol, morphine, gabapentin

Opioids
•Avoid morphine & oxycodone where possible
•Oxycodone with caution – use small doses with the increased time between

Safer opioids:
•Tramadol low dose is fine
•fentanyl, alfentanil, hydromorphone

110
Q

Consequences of unmanaged

lymphoedema

A

Cellulitis, pain, reduced mobility, body issues and psychological
impact, skin conditions, leg ulceration, social & financial impact, clothing & shoe issues, cost burden to the NHS.

111
Q

Main causes of Lymphoedema in End of Life

A
  • Often – Limb dependency
  • Cancer mass (internal or fungating tumours) causing an
    obstruction to the lymphatics
  • Consequence of cancer treatments
  • Low albumin

If sudden development, evaluate for DVT or SVCO

112
Q

Lymphorrhea

A

Lymphorrhea is an abnormal flow of lymph that drains externally from disrupted lymphatic vessels or is retained within a wound